Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Return on equity

Return on equity at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
4.6%-1.3pp
TFX
TeleflexTFX
-28.1%-31.6pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
2.9%-2.3pp
IAR
Integra LifeSciencesIART
-38.6%—
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp
PDE
Pro-Dex, Inc.PDEX
29.8%+1.5pp

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

net income/total stockholders equity=9.1%

Based on trailing twelve months.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's return on equity?
Utah Medical Products (UTMD) reported return on equity of 9.1% in Q1 2026.
How has Utah Medical Products's return on equity changed year-over-year?
Utah Medical Products's return on equity decreased by 13.7% year-over-year, from 10.6% to 9.1%.
What is the long-term trend for Utah Medical Products's return on equity?
Over 5 years (2020 to 2025), Utah Medical Products's return on equity has grown at a -2.1% compound annual growth rate (CAGR), from 10.6% to 9.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.